News from Thoratec

  • July 29, 2010

    Thoratec Reports 37 Percent Increase in Second Quarter Revenues From Continuing Operations

    PLEASANTON, Calif., July 29, 2010 /PRNewswire via COMTEX/ -- Thoratec Corporation (Nasdaq: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, said revenues from continuing operations in the second quarter of 2010 increased 37 percent versus the second quarter of 2009. Results from continuing operations for both periods exclude contributions from the company's International Technidyne Corporation (ITC) Division, which the company's board of directors agreed to sell during the second quarter. ITC's results for the second quarter and first six months of 2010 and 2009 are accounted for as a discontinued operation. The com...

  • July 27, 2010

    Thoratec Announces Termination of Proposed Sale of ITC

    ITC TO REMAIN AS A DISCONTINUED OPERATION PLEASANTON, Calif., July 27, 2010 /PRNewswire via COMTEX/ -- Thoratec Corporation (Nasdaq: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, announced today the termination, by mutual agreement, of the previously announced agreement to sell its International Technidyne Corporation (ITC) division to Danaher Corporation (NYSE: DHR). The termination came about as the result of the failure of the parties to agree about the status of certain aspects of ITC's quality system and regulatory filings. In addition, during the period since the agreement was signed, the ProTime InRhythm(R...

  • July 22, 2010

    Thoratec Schedules Second Quarter Conference Call, Webcast

    PLEASANTON, Calif., July 22, 2010 /PRNewswire via COMTEX/ -- Thoratec Corporation (Nasdaq: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, today announced that it will report its operating results for the second quarter and first six months of fiscal 2010 on Thursday, July 29. The company will hold a conference call to discuss its financial results and operating activities open to all interested parties at 1:30 p.m., Pacific Daylight Time (4:30 p.m., Eastern Daylight Time), Thursday, July 29, hosted by Gary F. Burbach, president and chief executive officer, and David V. Smith, executive vice president and chief f...

News from ITC

  • July 15, 2009

    MAS to Integrate ITC’s AVOXimeter® 4000 and AVOXimeter 1000E to RALS®-Plus

    International Technidyne Corporation (ITC) and Medical Automation Systems, Inc. (MAS) announced that they have entered into an agreement to add the ITC® AVOXimeter 4000 CO-oximeter and the AVOXimeter 1000E oximeters to the RALS®-Plus point-of-care (POC) data management system developed and marketed by MAS.

Stay in touch with us: